Carnosine and Lung Disease
- 23 April 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 27 (11) , 1714-1725
Abstract
Carnosine (β-alanyl-L-histidine) is a small dipeptide with numerous activities, including antioxidant effects, metal ion chelation, proton buffering capacity, and inhibitory effects on protein carbonylation and glycation. Carnosine has been mostly studied in organs where it is abundant, including skeletal muscle, cerebral cortex, kidney, spleen, and plasma. Recently, the effect of supplementation with carnosine has been studied in organs with low levels of carnosine, such as the lung, in animal models of influenza virus or lipopolysaccharide-induced acute lung injury and pulmonary fibrosis. Among the known protective effects of carnosine, its antioxidant effect has attracted increasing attention for potential use in treating lung disease. In this review, we describe the in vitro and in vivo biological and physiological actions of carnosine. We also report our recent study and discuss the roles of carnosine or its related compounds in organs where carnosine is present in only small amounts (especially the lung) and its protective mechanisms.Keywords
This publication has 103 references indexed in Scilit:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in ratsLife Sciences, 2012
- Determination of carnosine, anserine, homocarnosine, pentosidine and thiobarbituric acid reactive substances contents in meat from different animal speciesFood Chemistry, 2011
- Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD MicePLOS ONE, 2011
- Diminished Prostaglandin E2 Contributes to the Apoptosis Paradox in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Polaprezinc Protects Mice against Endotoxin ShockJournal of Clinical Biochemistry and Nutrition, 2010
- Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Genetic and Pharmacologic Evidence Links Oxidative Stress to Ventilator-induced Lung Injury in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Transforming Growth Factor β: A Central Modulator of Pulmonary and Airway Inflammation and FibrosisProceedings of the American Thoracic Society, 2006
- Classification and Natural History of the Idiopathic Interstitial PneumoniasProceedings of the American Thoracic Society, 2006